A2M | Alpha-2-macroglobulin | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
A2ML1 | Alpha-2-macroglobulin-like 1 | Predicted secreted proteins
| | | | | Tissue enriched |
A4GNT | Alpha-1,4-N-acetylglucosaminyltransferase | Predicted secreted proteins
| | | | | Tissue enriched |
AACS | Acetoacetyl-CoA synthetase | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
AASS | Aminoadipate-semialdehyde synthase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Mixed |
ABAT | 4-aminobutyrate aminotransferase | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | | Tissue enhanced |
ABCA1 | ATP-binding cassette, sub-family A (ABC1), member 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCA3 | ATP-binding cassette, sub-family A (ABC1), member 3 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCA7 | ATP-binding cassette, sub-family A (ABC1), member 7 | Predicted membrane proteins Transporters
| | | | | Mixed |
ABCA8 | ATP-binding cassette, sub-family A (ABC1), member 8 | Predicted membrane proteins Transporters
| | | | | Mixed |
ABCA9 | ATP-binding cassette, sub-family A (ABC1), member 9 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCB11 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ABCB4 | ATP-binding cassette, sub-family B (MDR/TAP), member 4 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ABCB7 | ATP-binding cassette, sub-family B (MDR/TAP), member 7 | Disease related genes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCB8 | ATP-binding cassette, sub-family B (MDR/TAP), member 8 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCC1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 | Cancer-related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCC11 | ATP-binding cassette, sub-family C (CFTR/MRP), member 11 | Predicted membrane proteins
| | | | | Tissue enhanced |
ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
ABCC3 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 | Cancer-related genes Predicted membrane proteins Transporters
| | | | | Mixed |
ABCC6 | ATP-binding cassette, sub-family C (CFTR/MRP), member 6 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCD2 | ATP-binding cassette, sub-family D (ALD), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCD3 | ATP-binding cassette, sub-family D (ALD), member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCG1 | ATP-binding cassette, sub-family G (WHITE), member 1 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
ABHD14A-ACY1 | ABHD14A-ACY1 readthrough (NMD candidate) | | | | | | Mixed |
ACAD9 | Acyl-CoA dehydrogenase family, member 9 | Disease related genes Mitochondrial proteins
| | | | | Expressed in all |
ACADVL | Acyl-CoA dehydrogenase, very long chain | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
ACBD5 | Acyl-CoA binding domain containing 5 | Predicted membrane proteins
| | | | | Expressed in all |
ACE | Angiotensin I converting enzyme | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ACE2 | Angiotensin I converting enzyme 2 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ACHE | Acetylcholinesterase (Yt blood group) | Blood group antigen proteins Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACKR2 | Atypical chemokine receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
ACLY | ATP citrate lyase | Cancer-related genes Citric acid cycle related proteins Enzymes Plasma proteins
| | | | | Expressed in all |
ACOX1 | Acyl-CoA oxidase 1, palmitoyl | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
ACOX2 | Acyl-CoA oxidase 2, branched chain | Enzymes
| | | | | Tissue enhanced |
ACP5 | Acid phosphatase 5, tartrate resistant | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
ACPP | Acid phosphatase, prostate | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACR | Acrosin | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
ACRBP | Acrosin binding protein | Predicted secreted proteins
| | | | | Tissue enriched |
ACSBG2 | Acyl-CoA synthetase bubblegum family member 2 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ACSF2 | Acyl-CoA synthetase family member 2 | Mitochondrial proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ACSF3 | Acyl-CoA synthetase family member 3 | Disease related genes Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
ACSL1 | Acyl-CoA synthetase long-chain family member 1 | Enzymes Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ACSL3 | Acyl-CoA synthetase long-chain family member 3 | Cancer-related genes Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
ACSL4 | Acyl-CoA synthetase long-chain family member 4 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ACSL5 | Acyl-CoA synthetase long-chain family member 5 | Enzymes Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ACSM5 | Acyl-CoA synthetase medium-chain family member 5 | Enzymes Mitochondrial proteins
| | | | | Tissue enriched |
ACSS1 | Acyl-CoA synthetase short-chain family member 1 | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
ACSS2 | Acyl-CoA synthetase short-chain family member 2 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |